202 related articles for article (PubMed ID: 24463937)
1. Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis.
Ocaranza MP; Moya J; Barrientos V; Alzamora R; Hevia D; Morales C; Pinto M; Escudero N; García L; Novoa U; Ayala P; Díaz-Araya G; Godoy I; Chiong M; Lavandero S; Jalil JE; Michea L
J Hypertens; 2014 Apr; 32(4):771-83. PubMed ID: 24463937
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
3. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart.
Lakó-Futó Z; Szokodi I; Sármán B; Földes G; Tokola H; Ilves M; Leskinen H; Vuolteenaho O; Skoumal R; deChâtel R; Ruskoaho H; Tóth M
Circulation; 2003 Nov; 108(19):2414-22. PubMed ID: 14568903
[TBL] [Abstract][Full Text] [Related]
5. Activation of angiotensin-(1-7)/Mas axis in the brain lowers blood pressure and attenuates cardiac remodeling in hypertensive transgenic (mRen2)27 rats.
Kangussu LM; Guimaraes PS; Nadu AP; Melo MB; Santos RA; Campagnole-Santos MJ
Neuropharmacology; 2015 Oct; 97():58-66. PubMed ID: 25983274
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-(1-9) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptor.
Flores-Munoz M; Work LM; Douglas K; Denby L; Dominiczak AF; Graham D; Nicklin SA
Hypertension; 2012 Feb; 59(2):300-7. PubMed ID: 22184331
[TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin inhibition reverses advanced cardiac remodeling in aging spontaneously hypertensive rats.
Ito N; Ohishi M; Yamamoto K; Tatara Y; Shiota A; Hayashi N; Komai N; Yanagitani Y; Rakugi H; Ogihara T
Am J Hypertens; 2007 Jul; 20(7):792-9. PubMed ID: 17586415
[TBL] [Abstract][Full Text] [Related]
8. Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.
Bao W; Behm DJ; Nerurkar SS; Ao Z; Bentley R; Mirabile RC; Johns DG; Woods TN; Doe CP; Coatney RW; Ohlstein JF; Douglas SA; Willette RN; Yue TL
J Cardiovasc Pharmacol; 2007 Jun; 49(6):362-8. PubMed ID: 17577100
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 1 receptor antagonist and angiotensin-converting enzyme inhibitor altered the activation of Cu/Zn-containing superoxide dismutase in the heart of stroke-prone spontaneously hypertensive rats.
Tanaka M; Umemoto S; Kawahara S; Kubo M; Itoh S; Umeji K; Matsuzaki M
Hypertens Res; 2005 Jan; 28(1):67-77. PubMed ID: 15969257
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
11. Treatment with angiotensin-(1-9) alleviates the cardiomyopathy in streptozotocin-induced diabetic rats.
Zheng H; Pu SY; Fan XF; Li XS; Zhang Y; Yuan J; Zhang YF; Yang JL
Biochem Pharmacol; 2015 May; 95(1):38-45. PubMed ID: 25801006
[TBL] [Abstract][Full Text] [Related]
12. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
Carnovali M
Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
[TBL] [Abstract][Full Text] [Related]
13. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling.
Ishibashi M; Hiasa K; Zhao Q; Inoue S; Ohtani K; Kitamoto S; Tsuchihashi M; Sugaya T; Charo IF; Kura S; Tsuzuki T; Ishibashi T; Takeshita A; Egashira K
Circ Res; 2004 May; 94(9):1203-10. PubMed ID: 15059935
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.
Jones ES; Black MJ; Widdop RE
J Mol Cell Cardiol; 2004 Nov; 37(5):1023-30. PubMed ID: 15522279
[TBL] [Abstract][Full Text] [Related]
15. Dissociating angiotensin 1-9 anticardiovascular remodeling effects from those on blood pressure.
Calò LA; Davis PA
J Hypertens; 2014 Aug; 32(8):1718-9. PubMed ID: 24991795
[No Abstract] [Full Text] [Related]
16. Reply: dissociating angiotensin 1-9 anticardiovascular remodeling effects from those on blood pressure.
Ocaranza MP; Michea L; Chiong M; Lavandero S; Jalil JE
J Hypertens; 2014 Aug; 32(8):1719-21. PubMed ID: 24991796
[No Abstract] [Full Text] [Related]
17. Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension.
Castoldi G; Carletti R; Ippolito S; Stella A; Zerbini G; Pelucchi S; Zatti G; di Gioia CRT
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948475
[TBL] [Abstract][Full Text] [Related]
18. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition.
Inaba S; Iwai M; Furuno M; Kanno H; Senba I; Okayama H; Mogi M; Higaki J; Horiuchi M
J Hypertens; 2011 Nov; 29(11):2236-45. PubMed ID: 21946695
[TBL] [Abstract][Full Text] [Related]
19. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension.
Yu Y; Fukuda N; Yao EH; Matsumoto T; Kobayashi N; Suzuki R; Tahira Y; Ueno T; Matsumoto K
Am J Hypertens; 2008 Jan; 21(1):72-7. PubMed ID: 18091747
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.
Bayorh MA; Ganafa AA; Eatman D; Walton M; Feuerstein GZ
Am J Hypertens; 2005 Nov; 18(11):1496-502. PubMed ID: 16280288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
